Table 2 Results of baseline testing
From: Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial
n | 691 |
Laboratory tests, median (Q1, Q3) unless specified | Â |
 N-terminal pro-B type natriuretic peptide, ng/L | 71 (35, 135) |
 High sensitivity cardiac troponin T, ng/L | 9 (6, 12) |
 Hemoglobin A1c, mean ± SD | 6.98 (0.79) |
 Hemoglobin, g/L, mean ± SD | 13.7 (1.4) |
 CKD-Epi, eGFR, mL/min/1.73m2, mean ± SD | 80.5 (16.3) |
 Albumin/Creatinine | 15 (8, 41) |
 Total cholesterol, mg/dL | 154 (133, 183) |
 High density lipoprotein cholesterol, mg/dL | 47 (39, 58) |
 Low density lipoprotein cholesterol, mg/dL | 72 (55, 97) |
 Triglycerides, mg/dL | 129 (101, 182) |
Echocardiographic measurements, median (Q1, Q3) | Â |
 E/e’ | 9.40 (7.80, 11.90) |
 Global longitudinal strain, % | -17.7 (-19.5, -15.2) |
 Left atrial volume index, mL/m2 | 23.4 (19.1, 28.9) |
 Left ventricular ejection fraction, % | 62 (59, 66) |
 Left ventricular mass index, g/m2 | 74 (64, 88) |
 Right ventricular systolic pressure, mmHg | 23 (19, 28) |
Abnormal echocardiogram, N, % | Â |
 Global longitudinal strain > -16% | 175 (25.3) |
 E/e’ ≥ 13 | 122 (17.7) |
 Left atrial volume index > 34 mL/m2 | 82 (11.9) |
 Left ventricular mass index ≥ 115 g/m2 in men and ≥ 95 g/m2 in women | 82 (11.9) |
 Right ventricular systolic pressure > 35 mmHg | 27 (3.9) |